Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was founded in 1996 and is headquartered in Chongqing, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.65 | N/A |
Market Cap | $687.08M | N/A |
Shares Outstanding | 417.60M | N/A |
Employees | 1.42K | N/A |